IL6 and rheumatoid arthritis: In the present study, the inhibition of pro-inflammatory cytokines especially the observed IL-6 levels under in vitro and in vivo conditions following DAR treatment could be correlated to a decrease in the pathogenesis of the RA disease in the animal models.